Similar articles for PMID: 21483009

Year	Number of Results
1945	1
1987	1
1990	2
1992	2
1993	1
1994	2
1995	1
1996	1
1998	1
1999	2
2001	1
2002	4
2003	4
2004	9
2005	11
2006	9
2007	26
2008	21
2009	21
2010	18
2011	21
2012	8
2013	16
2014	19
2015	6
2016	4
2017	3
2018	4
2019	3
2020	5
2021	4
2022	2
2023	1
2024	0

1

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

Rodriguez NA, Ascaso FJ. Rodriguez NA, et al. J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483009 No abstract available.

2

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

Bambury R, McCaffrey JA. Bambury R, et al. Clin Colorectal Cancer. 2009 Oct;8(4):235. doi: 10.3816/CCC.2009.n.040. Clin Colorectal Cancer. 2009. PMID: 19822516 No abstract available.

3

[Panitumumab-induced trichomegaly].

Vañó-Galván S, Longo F, Grillo E, Jaén P. Vañó-Galván S, et al. Med Clin (Barc). 2013 Apr 20;140(8):e15. doi: 10.1016/j.medcli.2013.01.006. Epub 2013 Mar 11. Med Clin (Barc). 2013. PMID: 23490492 Spanish. No abstract available.

4

The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.

Malik Z, Eng C. Malik Z, et al. Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):4-7. Clin Adv Hematol Oncol. 2007. PMID: 17491584 No abstract available.

5

Persistent hair growth during treatment with the EGFR inhibitor erlotinib.

Alexandrescu DT, Kauffman CL, Dasanu CA. Alexandrescu DT, et al. Dermatol Online J. 2009 Mar 15;15(3):4. Dermatol Online J. 2009. PMID: 19379648

6

Perforating dermatosis in a patient receiving bevacizumab.

Vano-Galvan S, Moreno C, Medina J, Pérez-García B, García-López JL, Jaén P. Vano-Galvan S, et al. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):972-4. doi: 10.1111/j.1468-3083.2008.03078.x. Epub 2009 Mar 17. J Eur Acad Dermatol Venereol. 2009. PMID: 19470057 No abstract available.

7

Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).

Foerster CG, Cursiefen C, Kruse FE. Foerster CG, et al. Cornea. 2008 Jun;27(5):612-4. doi: 10.1097/ICO.0b013e318166f483. Cornea. 2008. PMID: 18520515

8

[Secondary necrotizing fasciitis associated with panitumumab].

de Amuriza-Chicharro N, Gastalver-Martín C, Cortijo-Cascajares S, Ferrari-Piquero JM. de Amuriza-Chicharro N, et al. Med Clin (Barc). 2013 Nov 16;141(10):460-1. doi: 10.1016/j.medcli.2013.02.019. Epub 2013 Apr 23. Med Clin (Barc). 2013. PMID: 23622891 Spanish. No abstract available.

9

Liver resection after FOLFOX with bevacizumab.

Mickle M, Mulcahy MF. Mickle M, et al. Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):12-4. Clin Adv Hematol Oncol. 2007. PMID: 17491587 No abstract available.

10

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).

Márquez G, Herrera-Acosta E, Vidal I, Galvany L, Iglesias M, Umbert P. Márquez G, et al. Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x. Int J Dermatol. 2009. PMID: 19126063 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

216 results

Results by year